MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer.
暂无分享,去创建一个
Ming You | John Pfeifer | Ping Yang | Yan Lu | Xing Hua | Boone Goodgame | X. Hua | Yan Lu | R. Govindan | M. You | Liang Wang | Ping Yang | J. Pfeifer | B. Goodgame | Yian Wang | Liang Wang | Ramaswamy Govindan | P. Liu | W. Wen | Weidong Wen | Yian Wang | Peng-yuan Liu | Ananth Sezhiyan | Ya-fei Li | Yafei Li | Ananth Sezhiyan | Peng-Yuan Liu | Weidong Wen
[1] Yingdong Zhao,et al. MicroRNA Expression Differentiates Histology and Predicts Survival of Lung Cancer , 2010, Clinical Cancer Research.
[2] Gideon Rechavi,et al. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] Igor Jurisica,et al. Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study , 2008, Nature Medicine.
[4] A. Sahin,et al. Supplemental table 2 , 2014 .
[5] D. Olsen,et al. Brain metastasis model in athymic nude mice using a novel MUC1‐secreting human breast‐cancer cell line, MA11 , 1996, International journal of cancer.
[6] Hong Wang,et al. Protein profiles associated with survival in lung adenocarcinoma , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[7] Zhifu Sun,et al. A Gene Expression Signature Predicts Survival of Patients with Stage I Non-Small Cell Lung Cancer , 2006, PLoS medicine.
[8] R. Stephens,et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. , 2006, Cancer cell.
[9] Ying Feng,et al. Supplemental Data P53-mediated Activation of Mirna34 Candidate Tumor-suppressor Genes , 2022 .
[10] Xianglin Shi,et al. Constructing Molecular Classifiers for the Accurate Prognosis of Lung Adenocarcinoma , 2006, Clinical Cancer Research.
[11] L. Lim,et al. A microRNA component of the p53 tumour suppressor network , 2007, Nature.
[12] Marcin Skrzypski,et al. Three-Gene Expression Signature Predicts Survival in Early-Stage Squamous Cell Carcinoma of the Lung , 2008, Clinical Cancer Research.
[13] Michael A. Beer,et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. , 2007, Molecular cell.
[14] Cheng Cheng,et al. Robust estimation of the false discovery rate , 2006, Bioinform..
[15] Y. Mo,et al. MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. , 2010, Cancer research.
[16] C. Miller,et al. A Clinical Model to Estimate Recurrence Risk in Resected Stage I Non-Small Cell Lung Cancer , 2008, American journal of clinical oncology.
[17] E. Dmitrovsky,et al. MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. , 2010, The Journal of clinical investigation.
[18] H. Feilotter,et al. An array-based analysis of microRNA expression comparing matched frozen and formalin-fixed paraffin-embedded human tissue samples. , 2008, The Journal of molecular diagnostics : JMD.
[19] F. Slack,et al. RAS Is Regulated by the let-7 MicroRNA Family , 2005, Cell.
[20] M. Stratton,et al. COSMIC 2005 , 2006, British Journal of Cancer.
[21] Zhifu Sun,et al. Non-overlapping and non-cell-type-specific gene expression signatures predict lung cancer survival. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] N. Hayward,et al. Expression profiling defines a recurrence signature in lung squamous cell carcinoma. , 2006, Carcinogenesis.
[23] A. Borczuk,et al. Expression of syndecan‐1 and expression of epidermal growth factor receptor are associated with survival in patients with nonsmall cell lung carcinoma , 2004, Cancer.
[24] N. Hayward,et al. Gene Expression Signature Predicts Recurrence in Lung Adenocarcinoma , 2007, Clinical Cancer Research.
[25] Richard Wooster,et al. BRAF and RAS mutations in human lung cancer and melanoma. , 2002, Cancer research.
[26] Jiang Gui,et al. Partial Cox regression analysis for high-dimensional microarray gene expression data , 2004, ISMB/ECCB.
[27] C. Croce,et al. MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.
[28] S. Knudsen,et al. Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection. , 2010, Cancer research.
[29] D. Beer,et al. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. , 2009, Cancer research.
[30] Paul Ahlquist,et al. MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins , 2008, Proceedings of the National Academy of Sciences.
[31] Richard Simon,et al. Gene expression-based prognostic signatures in lung cancer: ready for clinical use? , 2010, Journal of the National Cancer Institute.
[32] D. Fan,et al. MiR-218 Inhibits Invasion and Metastasis of Gastric Cancer by Targeting the Robo1 Receptor , 2010, PLoS genetics.
[33] F. Slack,et al. The let-7 microRNA represses cell proliferation pathways in human cells. , 2007, Cancer research.
[34] Wei Wang,et al. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. , 2007, Cancer research.
[35] M. Fassan,et al. Classification of non-small cell lung carcinoma in transthoracic needle specimens using microRNA expression profiling. , 2011, Chest.